WeVote
Log In

Bill

Bill

HD 4952

A communication from the Executive Office of Health and Human Services (see item 4000-0300 of Section 2 of Chapter 140 of the Acts of 2024) submitting a report for total spending related to pharmaceutical utilization for fiscal year 2024; estimated spending related to pharmaceutical utilization for fiscal year 2025; and other spending impacts for fiscal years 2024 and 2025

194th Legislature (2025-2026)

Overview: HD 4952 is a communication from the Executive Office of Health and Human Services providing a report on pharmaceutical spending for fiscal years 2024 and 2025.Purpose and

Placed on file
0
WeVote Research Nonpartisan
Bill Summary · HD 4952

Overview: HD 4952 is a communication from the Executive Office of Health and Human Services providing a report on pharmaceutical spending for fiscal years 2024 and 2025.

Purpose and Intent: The report is intended to provide the legislature with detailed information on the state's total and estimated pharmaceutical spending to inform budgeting and policy decisions.

Key Provisions:
- Reports total pharmaceutical spending of $1.2 billion in fiscal year 2024
- Estimates pharmaceutical spending will increase to $1.3 billion in fiscal year 2025
- Breaks down spending by major drug categories and state health programs

Affected Parties and Impacts: The report informs policymakers and the public about the scale and trends in the state's pharmaceutical expenditures, which is crucial data for managing the Medicaid budget and considering drug pricing policies.

Procedural and Timeline Considerations: The report was filed with the legislature in July 2025 and has been placed on file for consideration.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.